Substituted 2-alkyl quinazolinone derivatives as PARP inhibitors

Details for Australian Patent Application No. 2005259192 (hide)

Owner Janssen Pharmaceutica N.V.

Inventors Van Dun, Jacobus Alphonsus Josephus; Wouters, Walter Boudewijn Leopold; Van Der AA, Marcel Jozef Maria; Van Heertum, Albertus Henricus Maria Theresia; Somers, Maria Victorina Francisca

Agent Shelston IP

Pub. Number AU-B-2005259192

PCT Pub. Number WO2006/003150

Priority 04076887.1 30.06.04 EP

Filing date 28 June 2005

Wipo publication date 12 January 2006

Acceptance publication date 28 April 2011

International Classifications

C07D 239/90 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

A61K 31/517 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

C07D 239/91 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

C07D 401/06 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 403/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 405/12 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

Event Publications

8 February 2007 PCT application entered the National Phase

  PCT publication WO2006/003150 Priority application(s): WO2006/003150

28 April 2011 Application Accepted

  Published as AU-B-2005259192

25 August 2011 Standard Patent Sealed

6 October 2011 Application for Amendment

  The nature of the amendment is as shown in the statement(s) filed 17 Aug 2011. Address for service in Australia - Shelston IP Level 21 60 Margaret Street Sydney NSW 2000

1 March 2012 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 17 Aug 2011

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005259205-Solid forms of the magnesium salt of (S)-omeprazole and processes for their preparation

2005259190-Quinazolinedione derivatives as PARP inhibitors